| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 4,852 | $20.10 | $97,525.20 | -1.4% | +2.9% | +54.6% | |
| Dec 8, 2023 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 500 | $57.52 | $28,760.00 | -2.4% | +57.6% | +195.2% | |
| Dec 7, 2023 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 62,467 | $130.00 | $8,120,710.00 | -16.9% | +13.6% | +9.2% | |
| Dec 6, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 100 | $20.02 | $2,002.00 | - | +14.6% | +65.3% | |
| Dec 6, 2023 | AWHL Aspira Women's Health Inc. | Sandford Nicole | President &CEO | Buy | 5,000 | $3.36 | $16,800.00 | +9.3% | - | - | |
| Dec 6, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 200 | $20.02 | $4,004.00 | -0.1% | +14.6% | +65.3% | |
| Dec 6, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,000 | $58.22 | $291,077.88 | -0.5% | +51.3% | +191.9% | |
| Dec 6, 2023 | AWHL Aspira Women's Health Inc. | Merchant Minh Hoang | Secretary &General Counsel | Sell | 980 | $3.37 | $3,302.60 | -100% | - | - | |
| Dec 5, 2023 | RDNT Radnet, Inc. | Murdock Michael N45 | EVP &Chief Development Offcr | Sell | 10,115 | $35.02 | $354,227.30 | -12.9% | +31.9% | +127.7% | |
| Dec 4, 2023 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $26.34 | $2,634.00 | -2.2% | -29.7% | +32.9% | |
| Dec 4, 2023 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 1,437 | $27.57 | $39,622.69 | -0.2% | -13.6% | -28.8% | |
| Dec 4, 2023 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,779 | $27.57 | $49,052.72 | -0.5% | -13.6% | -28.8% | |
| Dec 4, 2023 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,437 | $27.57 | $39,622.69 | -0.7% | -13.6% | -28.8% | |
| Dec 4, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 13,885 | $20.06 | $278,589.54 | -3.6% | +6.4% | +54.3% | |
| Dec 4, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 9,644 | $20.07 | $193,516.30 | -1.4% | +6.4% | +54.3% | |
| Dec 4, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 270 | $1.77 | $477.71 | -1.5% | +414.9% | +4213.2% | |
| Dec 1, 2023 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Sell | 5,800 | $26.37 | $152,954.12 | -49.5% | -27.8% | +35.2% | |
| Dec 1, 2023 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 13,117 | $214.03 | $2,807,471.70 | -31.4% | +13.9% | -7.4% | |
| Dec 1, 2023 | WST West Pharmaceutical Services Inc | Winters Chad | VP, Chief Accounting Officer | Sell | 1,013 | $349.00 | $353,541.25 | -44.4% | +1.9% | -7.4% | |
| Dec 1, 2023 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 30,000 | $19.09 | $572,835.00 | -9.3% | +8.8% | -15.4% | |
| Dec 1, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 53,167 | $272.86 | $14,507,101.01 | -0.2% | +44.3% | +23.7% | |
| Dec 1, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 53,167 | $272.86 | $14,507,101.01 | -0.2% | +44.3% | +23.7% | |
| Nov 30, 2023 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 1,850 | $197.73 | $365,800.50 | -7.4% | +30.3% | +1.0% | |
| Nov 30, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 29,521 | $20.11 | $593,574.25 | -6.8% | +22.0% | +51.5% | |
| Nov 30, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 21,429 | $20.10 | $430,800.27 | -2.9% | +22.0% | +51.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.